A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
Mesothelin and osteopontin as diagnostic and prognostic markers of malignant pleural mesothelioma in Egyptian patients undergoing pleurodesis
2013
Egyptian Journal of Chest Disease and Tuberculosis
KEYWORDS Mesothelin Osteopontin Malignant pleural mesothelioma Pleurodesis Abstract Purpose: In malignant pleural mesothelioma (MPM), early assessment of disease status is important. We evaluated the role of mesothelin and osteopontin biomarkers in distinguishing MPM from benign pleural disease. We also, evaluated whether mesothelin and osteopontin were related to successful pleurodesis or not. Materials and methods: Mesothelin and osteopontin were assayed in blood and pleural fluid with
doi:10.1016/j.ejcdt.2013.04.005
fatcat:el4qkynvm5hldlt3pzloqpyn5m